Flash Finance

Dr Agarwals Eye Hospital Ltd526783Corporate

Hospital Latest results: Jun 2026 14 quarters of data
₹5,278.65
MCap ₹2,465 Cr · P/E 32.7
Dr Agarwals Eye Hospital Ltd — Stock analysis & AI research Dr Agarwals Eye Hospital Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹143 Cr
Sales · Jun 2026
+22.2% YoY
₹43 Cr
Operating Profit · Jun 2026
+16.9% YoY
30.3%
OPM % · Jun 2026
-4.1% YoY
₹23 Cr
Net Profit · Jun 2026
+37.5% YoY
₹48.38
EPS · Jun 2026
+31.8% YoY

📝 Dr Agarwals Eye Hospital Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Dr Agarwals Eye Hospital Ltd reported revenue of ₹143 crore for the quarter ended June 2026 (Q1 FY27), up 22.2% from ₹117 crore in the same quarter last year, and up 19.1% sequentially over the March 2026 quarter.

Net profit rose 37.5% year-on-year to ₹23 crore, from ₹17 crore. Earnings per share (EPS) came in at ₹48.38.

Operating profit stood at ₹43 crore — an operating margin (OPM) of 30.3%, compared with 31.6% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Dr Agarwals Eye Hospital Ltd posted revenue of ₹471 crore, a growth of 18.6% over FY25, with a net profit of ₹69 crore (up 27.8% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹497 crore with a net profit of ₹75 crore.

Valuation snapshot

At the current price of ₹5,278.65, 526783 has a market capitalisation of ₹2,465 crore and a trailing P/E of about 32.7.

Within the Hospital industry, it is the 2nd-largest of the 10 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 72.67%, foreign institutional investors (FIIs) 2.24%, domestic institutional investors (DIIs) 2.05%, public shareholders 23.03% of Dr Agarwals Eye Hospital Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹2,465 Cr
Current Price ?
₹5,278.6
P/E ?
32.70below ind
Industry P/E ?
39.60
P/B ?
7.12
P/S ?
4.96
P/FCF ?
52.45
Enterprise Value ?
₹2,791 Cr
EV/EBITDA ?
18.45
PEG ?
1.36
Earnings Yield ?
3.8%
Dividend Yield ?
0.11%
Profitability & Returns
Sales (TTM) ?
₹497 Cr
OPM ?
30.4%
Profit after tax (TTM) ?
₹75 Cr
EPS (TTM) ?
₹161.42
ROCE ?
17.0%
ROE ?
21.8%
ROA ?
9.8%
Growth
Sales — latest qtr ?
₹143 Cr
PAT — latest qtr ?
₹23 Cr
YoY qtr sales growth ?
22.2%
YoY qtr profit growth ?
37.5%
Sales growth (3y) ?
21%
Sales growth (5y) ?
27%
Profit growth (3y) ?
24%
Profit growth (5y) ?
120%
Financial Health
Debt ?
₹326 Cr
Debt to Equity ?
0.94
Interest Coverage ?
8.2
Current Ratio ?
N/A
Ownership
Promoter holding ?
72.67%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
5.7%
Return 6 months ?
10.7%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 697984768110010295100117118116120143 +22.2% +19.1%
Operating Profit 2123232124313026323740343443 +16.9% +27.2%
Other Income 00112022011322 +96.0% -2.0%
Interest 22222344344223 -30.8% +38.5%
Depreciation 2667810910101111121211 +4.5% -4.2%
Profit Before Tax 1816171317191914192326232131 +34.6% +47.4%
Net Profit 141213913141410161719171623 +37.5% +46.1%
EPS 29.1124.5526.7920.0927.2130.0230.1122.1334.0236.7239.9835.7633.6048.38 +31.8% +44.0%
OPM % 30.4% 29.1% 27.4% 27.6% 29.6% 31.0% 29.4% 27.4% 32.0% 31.6% 33.9% 29.3% 28.3% 30.3% -4.1% +7.1%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹397 Cr ₹471 Cr ₹497 Cr +18.6%
Operating Profit ₹119 Cr ₹145 Cr ₹151 Cr +21.8%
OPM % 29.97% 30.79% 30.44% +2.7%
NPM % 13.60% 14.65% 15.17% +7.7%
Other Income ₹4 Cr ₹7 Cr ₹8 Cr +75.0%
Depreciation ₹39 Cr ₹46 Cr ₹46 Cr +17.9%
Interest ₹14 Cr ₹12 Cr ₹11 Cr -14.3%
EBIT ₹80 Cr ₹99 Cr ₹105 Cr +23.8%
PBT ₹71 Cr ₹93 Cr ₹101 Cr +31.0%
Tax — — ₹8 Cr —
Net Profit ₹54 Cr ₹69 Cr ₹75 Cr +27.8%
EPS ₹116.28 ₹146.06 ₹157.72 +25.6%
Material Cost — — ₹31 Cr —
Employee Cost — — ₹27 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 5555 +0.0%
Reserves 109152205341 +66.3%
Borrowings 232268333326 -2.1%
Other Liabilities 44717194 +32.4%
Total Liabilities 390496613766 +25.0%
Fixed Assets 260316393403 +2.5%
CWIP 6297128197 +53.9%
Investments 001389 +584.6%
Other Assets 67838078 -2.5%
Total Assets 390496613766 +25.0%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 709094145 +54.3%
Cash from Investing Activity -71-70-133-174 -30.8%
Cash from Financing Activity 0-141725 +47.1%
Net Cash Flow -16-22-4 +81.8%
Free Cash Flow -119-847 +687.5%
CFO/OP 107%112%95%106% +11.6%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 14151314 +7.7%
Inventory Days 73106117109 -6.8%
Days Payable 327345263208 -20.9%
Cash Conversion Cycle -240-224-133-84 +36.8%
Working Capital Days -50-63-5114 +127.5%
ROCE % 19%18%18%17% -5.6%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 72.67%72.67%72.67%72.67% +0.0%
FIIs 1.74%1.82%2.20%2.24% +1.8%
DIIs 2.36%2.36%2.12%2.05% -3.3%
Public 23.22%23.15%22.99%23.03% +0.2%
No. of Shareholders 30,52825,44924,03622,954 -4.5%

⚖️ Peer comparison

Industry: Hospital · 10 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 PARKHOSPS Park Medi ₹280.90 12,133 42.4 1,756 298 26.5% 16.9% — — 19.3% 34.8%
2 526783 Dr Agarwals ₹5,253.00 2,465 33.3 497 75 30.4% 15.2% 18.6% 27.8% 22.2% 37.5%
3 524520 KMC Speciality ₹81.32 2,373 23.8 331 57 30.4% 17.1% 32.5% 108.7% 37.0% 107.2%
4 GKSL Gujarat Kidney ₹172.33 1,359 — — — — — — — — —
5 543346 Aashka Hospitals ₹117.80 195 83.0 23 3 22.8% 14.5% — — 22.3% 55.2%
6 531658 Abate As ₹28.64 120 266.9 — 2 — — — 158.6% — 10.1%
7 523696 Fortis Malar ₹65.66 79 n/m 0 0 -5165.0% 427.8% — 932.5% -95.5% -96.3%
8 544013 KK Shah ₹49.79 30 — 9 -1 8.2% -6.6% — — -7.2% 57.1%
9 539378 Soni Medicare ₹26.49 30 — 23 -4 -8.1% -15.5% -15.9% -1405.6% -39.2% -313.3%
10 543520 Global Longlife ₹30.99 16 — — -2 — — — — — 61.5%
❓ Frequently asked questions
What was Dr Agarwals Eye Hospital Ltd's revenue in Q1 FY27?
Dr Agarwals Eye Hospital Ltd reported revenue of ₹143 crore for the quarter ended June 2026 (Q1 FY27), up 22.2% from ₹117 crore in the same quarter last year, and up 19.1% sequentially over the March 2026 quarter.
What was Dr Agarwals Eye Hospital Ltd's net profit in Q1 FY27?
Net profit rose 37.5% year-on-year to ₹23 crore, from ₹17 crore. Earnings per share (EPS) came in at ₹48.38.
What is 526783's market capitalisation and P/E ratio?
At the current price of ₹5,278.65, 526783 has a market capitalisation of ₹2,465 crore and a trailing P/E of about 32.7.
Who owns Dr Agarwals Eye Hospital Ltd? (shareholding pattern)
As of Jun 2026, promoters held 72.67%, foreign institutional investors (FIIs) 2.24%, domestic institutional investors (DIIs) 2.05%, public shareholders 23.03% of Dr Agarwals Eye Hospital Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI